Vlad Ratziu is a Professor of Hepatology at Sorbonne University, and performs his hospital work at the Pitié-Salpêtrière Hospital and the Institute for Cardiometabolism and Nutrition (ICAN) in Paris, France. Professor Ratziu received his medical training at Paris Descartes University; he then completed a 2-year postdoctoral fellowship at the Liver Center at the University of California, San Francisco, CA, and went on to earn a doctoral degree from Paris Diderot University for his work on the pathophysiology of viral and metabolic liver fibrosis.
Professor Ratziu’s main research interests are in particular the mechanisms, risk factors, and progression of liver fibrosis, non-invasive biomarkers and digital pathology and the determinants of hepatocarcinogenesis in patients with metabolic dysfunction. He coordinated or participated in several therapeutic trials in NASH. He was also involved in different European financed FP7, Horizon 2020, and Innovative Medicines Initiative 2 consortia. He is a member of the organizing committee of the NASH-TAG meetings. He is a Senior Editor for the Journal of Hepatology. He has published more than 360 articles.